Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer

BACKGROUND: Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been recognised as standard treatments in metastatic colorectal cancer (mCRC), the best option remains unclear. Pretreatment tumour growth rate (TGR) is associated with radiotherapeutic efficacy in laryngeal cancer. How...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESMO Open
Main Authors: Masuishi, Toshiki, Taniguchi, Hiroya, Kawakami, Takeshi, Kawamoto, Yasuyuki, Kadowaki, Shigenori, Onozawa, Yusuke, Muranaka, Tetsuhito, Tajika, Masahiro, Yasui, Hirofumi, Nakatsumi, Hiroshi, Yuki, Satoshi, Muro, Kei, Omae, Katsuhiro, Komatsu, Yoshito, Yamazaki, Kentaro
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001098/
https://ncbi.nlm.nih.gov/pubmed/32392174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados